The FDA is continuing, under certain conditions, the flexibilities regarding importation and domestic production of certain infant formula products as part of its effort to provide stable, longer-term access to safe and nutritious infant formula across the country.
Read more: FDA Pathway Supports Long-Term Stability, Diversity of Safe and Nutritious Infant Formula Supply in the U.S.